4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: April 4, 2019
Period of Report: March 27, 2019
Accession Number: 0001645470-19-000022

View Document ↗ View on SEC.gov ↗